Abstract
Genome-wide association studies (GWAS) have revealed that different diseases share susceptibility variants. Twelve single-nucleotide polymorphisms (SNPs) previously associated with different immune-mediated diseases in GWAS were genotyped in a Caucasian Spanish population of 2864 multiple sclerosis (MS) patients and 2930 controls. Three SNPs were found to be associated with MS: rs1678542 in KIF5A (P=0.001, odds ratio (OR)=1.13, 95% confidence interval (CI)=1.05–1.23); rs3184504 in SH2B3 (P=0.00001, OR=1.19, 95% CI=1.10–1.27) and rs763361 in CD226 (P=0.00007, OR=1.16, 95%CI=1.08–1.25). These variants have previously been associated with rheumatoid arthritis and type 1 diabetes. The SH2B3 polymorphism has additionally been associated with systemic lupus erythematosus. Our results, in addition to validating some of these loci as risk factors for MS, are consistent with shared genetic mechanisms underlying different immune-mediated diseases. These data may help to shape the contribution of each pathway to different disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hauser SL, Oksenberg JR . The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006; 52: 61–76.
Ramagopalan SV, Knight JC, Ebers GC . Multiple sclerosis and the major histocompatibility complex. Curr Opin Neurol 2009; 22: 219–225.
Oliver B, Mayorga C, Fernández V, Leyva L, León A, Luque G et al. Multiple sclerosis in Gypsies from southern Spain: prevalence, mitochondrial DNA haplogroups and HLA class II association. Tissue Antigens 2008; 71: 426–433.
McElroy JP, Oksenberg JR . Multiple sclerosis genetics. Curr Top Microbiol Immunol 2008; 318: 45–72.
Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC, Canadian Collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci USA 2003; 100: 12877–12882.
Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009; 18: 767–778.
Australia New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009; 41: 824–828.
International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851–862.
Somers EC, Thomas SL, Smeeth L, Hall AJ . Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology 2006; 17: 202–217.
Corporaal S, Bijl M, Kallenberg CG . Familial occurrence of autoimmune diseases and autoantibodies in a Caucasian population of patients with systemic lupus erythematosus. Clin Rheumatol 2002; 21: 108–113.
Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases-a meta-analysis. Rheumatology 2007; 46: 49–56.
Kristjansdottir G, Sandling JK, Bonetti A, Roos IM, Milani L, Wang C et al. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet 2008; 45: 362–369.
Sigurdsson S, Padyukov L, Kurreeman FA, Liljedahl U, Wiman AC, Alfredsson L et al. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum 2007; 56: 2202–2210.
Sigurdsson S, Nordmark G, Göring HH, Lindroos K, Wiman AC, Sturfelt G et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005; 76: 528–537.
Lowe CE, Cooper JD, Brusko T, Walker NM, Smyth DJ, Bailey R et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet 2007; 39: 1074–1082.
Alcina A, Fedetz M, Ndagire D, Fernández O, Leyva L, Guerrero M et al. IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D). PLoS One 2009; 4: e4137.
International Multiple Sclerosis Genetics Consortium (IMSGC). The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun 2009; 10: 11–14.
Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40: 1216–1223.
Kozyrev SV, Abelson AK, Wojcik J, Zaghlool A, Linga Reddy MV, Sanchez E et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008; 40: 211–216.
Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S . Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008; 358: 900–909.
Sims AM, Timms AE, Bruges-Armas J, Burgos-Vargas R, Chou CT, Doan T et al. Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis 2008; 67: 1305–1309.
Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, et al., Wellcome Trust Case Control Consortium; Australo-Anglo-American Spondylitis Consortium (TASC). Association scan of 14 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39: 1329–1337.
Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, et al., Wellcome Trust CaseControl Consortium. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39: 857–864.
Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009; 41: 199–204.
Hafler JP, Maier LM, Cooper JD, Plagnol V, Hinks A, Simmonds MJ et al. CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun 2009; 10: 5–10.
De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009; 41: 776–782.
Wellcome Trust CaseControl Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661–678.
Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009; 41: 1228–1233.
Takaki S, Tezuka Y, Sauer K, Kubo C, Kwon SM, Armstead E et al. Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing Lnk adaptor protein. J Immunol 2003; 170: 703–710.
Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J et al. Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. Nat Genet 2008; 40: 1156–1159.
Fung EY, Smyth DJ, Howson JM, Cooper JD, Walker NM, Stevens H et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun 2009; 10: 188–191.
Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227–231.
González JR, Armengol L, Solé X, Guinó E, Mercader JM, Estivill X et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007; 23: 644–645.
Benjamini Y, Hochberg Y . Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B 1995; 57: 289–300.
Guo L, Deshmukh H, Lu R, Vidal GS, Kelly JA, Kaufman KM et al. Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population. Genes Immun 2009; 10: 531–538.
Suarez-Gestal M, Calaza M, Endreffy E, Pullmann R, Ordi-Ros J, Domenico Sebastiani G et al. Identified systemic lupus erythematosus genetic associations: a case-control study. Arthritis Res Ther 2009; 11: R69.
Orozco G, Abelson AK, González-Gay MA, Balsa A, Pascual-Salcedo D, García A et al. Study of functional variants of the BANK1 gene in rheumatoid arthritis. Arthritis Rheum 2009; 60: 372–379.
Suarez-Gestal M, Calaza M, Dieguez-Gonzalez R, Perez-Pampin E, Pablos JL, Navarro F et al. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors. Arthritis Rheum 2009; 60: 2558–2564.
Gregersen PK, Amos CI, Lee AT, Lu Y, Remmers EF, Kastner DL et al. REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet 2009; 41: 820–823.
Gourh P, Agarwal SK, Martin E, Divecha D, Rueda B, Bunting H et al. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. J Autoimmun 2010; 34: 155–162.
Yin H, Borghi MO, Delgado-Vega AM, Tincani A, Meroni PL, Alarcón-Riquelme ME . Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome. Arthritis Rheum 2009; 60: 2468–2471.
Lee HS, Korman BD, Le JM, Kastner DL, Remmers EF, Gregersen PK et al. Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. Arthritis Rheum 2009; 60: 364–371.
Orozco G, Eyre S, Hinks A, Ke X, Wilson AG, Bax DE et al. Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study. Ann Rheum Dis 2010; 69: 813–816.
Coenen MJ, Trynka G, Heskamp S, Franke B, van Diemen CC, Smolonska J et al. Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet 2009; 18: 4195–4203.
Acknowledgements
We thank the patients with multiple sclerosis and persons who acted as controls for making this study possible. Financial support for the study was provided by Fondos Europeos de Desarrollo Regional (FEDER), Ministerio de Ciencia e Innovación (SAF2006-02023 and SAF2009-11491), Junta de Andalucía (P07-CVI-02551), Fondo de Investigación Sanitaria (RETICS-REEM RD07/0060, PI081636, PI070353, PS0902105), Ikerbasque, Basque Foundation for Science, Bilbao and Fundación ILUNDAIN. Genotyping services were provided by the Spanish ‘Centro Nacional de Genotipado’ CEGEN-USC (www.cegen.org).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Alcina, A., Vandenbroeck, K., Otaegui, D. et al. The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun 11, 439–445 (2010). https://doi.org/10.1038/gene.2010.30
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gene.2010.30
Keywords
This article is cited by
-
Systemic aspergillosis in a patient with interferon gamma receptor 1 deficiency; a case report
BMC Pediatrics (2023)
-
Normal levels of KIF5 but reduced KLC1 levels in both Alzheimer disease and Alzheimer disease in Down syndrome: evidence suggesting defects in anterograde transport
Alzheimer's Research & Therapy (2021)
-
Structural and functional analysis of target recognition by the lymphocyte adaptor protein LNK
Nature Communications (2021)
-
Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis
Acta Neuropathologica Communications (2019)
-
The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders
Leukemia (2017)